Previous Article | Next Article 
Journal of Virology, November 2004, p. 12625-12637, Vol. 78, No. 22
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.22.12625-12637.2004
Copyright © 2004, American
Society for
Microbiology. All Rights Reserved.
Evolutionary Dynamics of the Glycan Shield of the Human Immunodeficiency Virus Envelope during Natural Infection and Implications for Exposure of the 2G12 Epitope
Laurent Dacheux,1
Alain Moreau,1
Yasemin Ataman-Önal,2
François Biron,3
Bernard Verrier,2 and
Francis Barin1*
Laboratoire
de Virologie, Equipe Associée 3856, Université
François Rabelais,
Tours,1
FRE 2736
CNRS-BioMérieux, Institut Fédératif de Recherche
128,2
Service des Maladies
Infectieuses, Hôpital de la Croix-Rousse,Lyon, France3
Received 31 March 2004/
Accepted 13 July 2004
Elucidation
of the kinetics of exposure of neutralizing epitopes on the envelope of
human immunodeficiency virus type 1 (HIV-1) during the course of
infection may provide key information about how HIV escapes the immune
system or why its envelope is such a poor immunogen to induce broadly
efficient neutralizing antibodies. We analyzed the kinetics of exposure
of the epitopes corresponding to the broadly neutralizing human
monoclonal antibodies immunoglobulin G1b12 (IgG1b12), 2G12, and 2F5 at
the quasispecies level during infection. We studied the antigenicity
and sequences of 94 full-length envelope clones present during primary
infection and at least 4 years later in four HIV-1 clade B-infected
patients. No or only minor exposure differences were observed for the
2F5 and IgG1b12 epitopes between the early and late clones. Conversely,
the envelope glycoproteins of the HIV-1 quasispecies present during
primary infection did not expose the 2G12 neutralizing epitope, unlike
those present after several years in three of the four patients.
Sequence analysis revealed major differences at potential N-linked
glycosylation sites between early and late clones, particularly at
positions known to be important for 2G12 binding. Our study, in natural
mutants, confirms that the glycosylation sites N295, N332, and N392 are
essential for 2G12 binding. This study demonstrates the relationship
between the evolving "glycan shield " of HIV and the
kinetics of exposure of the 2G12 epitope during the course of natural
infection.
* Corresponding
author. Mailing address: Laboratoire de Virologie, CHU Bretonneau,
37044 Tours cedex, France. Phone: 332 47 47 80 58. Fax: 332 47 47 36
10. E-mail:
fbarin{at}med.univ-tours.fr.
Journal of Virology, November 2004, p. 12625-12637, Vol. 78, No. 22
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.22.12625-12637.2004
Copyright © 2004, American
Society for
Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Beaumont, E., Vendrame, D., Verrier, B., Roch, E., Biron, F., Barin, F., Mammano, F., Brand, D.
(2009). Matrix and Envelope Coevolution Revealed in a Patient Monitored since Primary Infection with Human Immunodeficiency Virus Type 1. J. Virol.
83: 9875-9889
[Abstract]
[Full Text]
-
Blay, W. M., Kasprzyk, T., Misher, L., Richardson, B. A., Haigwood, N. L.
(2007). Mutations in Envelope gp120 Can Impact Proteolytic Processing of the gp160 Precursor and Thereby Affect Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Pseudoviruses. J. Virol.
81: 13037-13049
[Abstract]
[Full Text]
-
Quakkelaar, E. D., van Alphen, F. P. J., Boeser-Nunnink, B. D. M., van Nuenen, A. C., Pantophlet, R., Schuitemaker, H.
(2007). Susceptibility of Recently Transmitted Subtype B Human Immunodeficiency Virus Type 1 Variants to Broadly Neutralizing Antibodies. J. Virol.
81: 8533-8542
[Abstract]
[Full Text]
-
Lambele, M., Labrosse, B., Roch, E., Moreau, A., Verrier, B., Barin, F., Roingeard, P., Mammano, F., Brand, D.
(2007). Impact of Natural Polymorphism within the gp41 Cytoplasmic Tail of Human Immunodeficiency Virus Type 1 on the Intracellular Distribution of Envelope Glycoproteins and Viral Assembly. J. Virol.
81: 125-140
[Abstract]
[Full Text]
-
Pashov, A. D., Plaxco, J., Kaveri, S. V., Monzavi-Karbassi, B., Harn, D., Kieber-Emmons, T.
(2006). Multiple Antigenic Mimotopes of HIV Carbohydrate Antigens: Relating Structure and Antigenicity. J. Biol. Chem.
281: 29675-29683
[Abstract]
[Full Text]
-
Blay, W.M., Gnanakaran, S., Foley, B., Doria-Rose, N. A., Korber, B. T., Haigwood, N. L.
(2006). Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques. J. Virol.
80: 999-1014
[Abstract]
[Full Text]
-
Pashov, A., MacLeod, S., Saha, R., Perry, M., VanCott, T. C., Kieber-Emmons, T.
(2005). Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12. Glycobiology
15: 994-1001
[Abstract]
[Full Text]
-
Qiao, Z.-S., Kim, M., Reinhold, B., Montefiori, D., Wang, J.-h., Reinherz, E. L.
(2005). Design, Expression, and Immunogenicity of a Soluble HIV Trimeric Envelope Fragment Adopting a Prefusion gp41 Configuration. J. Biol. Chem.
280: 23138-23146
[Abstract]
[Full Text]